Literature DB >> 17485146

New cerium(III) complexes of coumarins - synthesis, characterization and cytotoxicity evaluation.

Irena Kostova1, Georgi Momekov.   

Abstract

Complexes of cerium(III) with bis(4-hydroxy-2-oxo-2H-chromen-3-yl)-pyridin-2-yl-methane, bis(4-hydroxy-2-oxo-2H-chromen-3-yl)-pyridin-3-yl-methane and bis(4-hydroxy-2-oxo-2H-chromen-3-yl)-pyridin-4-yl-methane were synthesized by reaction of cerium(III) salt and the ligands, in amounts equal to metal-ligand molar ratio of 1:2. The cerium(III) complexes with bis-coumarins were characterized by different physicochemical methods - elemental analysis, IR-, Raman-, (1)H NMR- and (13)C NMR-spectroscopy and mass-spectral data. The spectral data of cerium(III) complexes were interpreted on the basis of comparison with the spectra of the free ligands. This analysis showed that in the Ce(III) complexes the ligands coordinated to the metal ion through both deprotonated hydroxyl groups. On the basis of the nu(CO) red shift observed, participation of the carbonyl groups in the coordination to the metal ion was also suggested. Cytotoxic screening by MTT assay was carried out. In the present study we performed comparative evaluation of the cytotoxic effects of the three newly synthesized cerium complexes against the acute myeloid leukemia derived HL-60 and the chronic myeloid leukemia (CML)-derived BV-173. In addition the cytotoxic effects of Ce(III) complex with bis(4-hydroxy-2-oxo-2H-chromen-3-yl)-pyridin-2-yl-methane were evaluated on the SKW-3 cells. In order to elucidate some of the mechanistic aspects of the observed cytotoxic effects we evaluated the ability of this complex to trigger programmed cell death (apoptosis by means of agarose gel electrophoretic analysis of DNA, isolated from the cytosolic fraction of treated SKW-3 cells). In addition, microscopic morphological evaluation of the treated cells was carried out in order to establish morphological features indicative of programmed cell death.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17485146     DOI: 10.1016/j.ejmech.2007.03.007

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  5 in total

1.  High in Vitro and in Vivo Tumor-Selective Novel Ruthenium(II) Complexes with 3-(2'-Benzimidazolyl)-7-fluoro-coumarin.

Authors:  Qi-Pin Qin; Zhen-Feng Wang; Xiao-Ling Huang; Ming-Xiong Tan; Bei-Bei Shi; Hong Liang
Journal:  ACS Med Chem Lett       Date:  2019-05-22       Impact factor: 4.345

2.  Lanthanide(III) complexes are more active inhibitors of the Fenton reaction than pure ligands.

Authors:  Jan Martin; Přemysl Mladěnka; Luciano Saso; Irena Kostova
Journal:  Redox Rep       Date:  2016-02-18       Impact factor: 4.412

3.  Synthesis, Characterization, DNA Interaction, and Antitumor Activities of La (III) Complex with Schiff Base Ligand Derived from Kaempferol and Diethylenetriamine.

Authors:  Qin Wang; Yu Huang; Jin-Sheng Zhang; Xin-Bin Yang
Journal:  Bioinorg Chem Appl       Date:  2014-10-12       Impact factor: 7.778

4.  In vitro cytotoxicity activity of novel Schiff base ligand-lanthanide complexes.

Authors:  Kavitha Andiappan; Anandhavelu Sanmugam; Easwaramoorthy Deivanayagam; K Karuppasamy; Hyun-Seok Kim; Dhanasekaran Vikraman
Journal:  Sci Rep       Date:  2018-02-14       Impact factor: 4.379

5.  Caffeic Acid/Eu(III) Complexes: Solution Equilibrium Studies, Structure Characterization and Biological Activity.

Authors:  Żaneta Arciszewska; Sofia Gama; Monika Kalinowska; Grzegorz Świderski; Renata Świsłocka; Ewelina Gołębiewska; Monika Naumowicz; Mateusz Worobiczuk; Adam Cudowski; Anna Pietryczuk; Concetta De Stefano; Demetrio Milea; Włodzimierz Lewandowski; Beata Godlewska-Żyłkiewicz
Journal:  Int J Mol Sci       Date:  2022-01-14       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.